Literature DB >> 18930381

Cross-validation of brain segmentation by SPM5 and SIENAX.

Hedok Lee1, Isak Prohovnik.   

Abstract

Volumes of cerebral grey (GM) or white matter (WM) are often used as clinical observations or statistical covariates. Several automated segmentation tools can be used for this purpose, but they have not been validated against each other. We used the most common ones, SPM5 and SIENAX 2.4, to derive volumes of grey and white matter in 56 healthy subjects (mean age 49+/-13, range 22-80) and compared the two methods. Both methods yielded significant correlations with age in the expected directions, and estimates of parenchymal volumes were highly correlated. However, without use of prior probability maps, or priors, in SIENAX, GM was significantly underestimated in comparison to SPM (0.52+/-.06 vs 0.66+/-.07 L) and WM was significantly overestimated (0.48+/-.07 vs 0.46+/-.07 L). This error was associated with misclassification of GM as cerebrospinal fluid, especially in deep grey matter. Invoking prior probabilities in SIENAX resulted in excellent agreement with SPM: GM and WM volumes were found to be 0.64+/-0.07 L and 0.47+/-0.07 L, respectively. We conclude that SIENAX requires priors for accurate volumetric estimates, and then provides close agreement with SPM5.

Entities:  

Mesh:

Year:  2008        PMID: 18930381      PMCID: PMC2778005          DOI: 10.1016/j.pscychresns.2007.12.008

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  25 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry.

Authors:  G B Karas; E J Burton; S A R B Rombouts; R A van Schijndel; J T O'Brien; P h Scheltens; I G McKeith; D Williams; C Ballard; F Barkhof
Journal:  Neuroimage       Date:  2003-04       Impact factor: 6.556

3.  Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.

Authors:  G Douaud; V Gaura; M-J Ribeiro; F Lethimonnier; R Maroy; C Verny; P Krystkowiak; P Damier; A-C Bachoud-Levi; P Hantraye; P Remy
Journal:  Neuroimage       Date:  2006-07-27       Impact factor: 6.556

Review 4.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

5.  Sequence-independent segmentation of magnetic resonance images.

Authors:  Bruce Fischl; David H Salat; André J W van der Kouwe; Nikos Makris; Florent Ségonne; Brian T Quinn; Anders M Dale
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

6.  Reliability and validity of an algorithm for fuzzy tissue segmentation of MRI.

Authors:  A L Reiss; J G Hennessey; M Rubin; L Beach; M T Abrams; I S Warsofsky; A M Liu; J M Links
Journal:  J Comput Assist Tomogr       Date:  1998 May-Jun       Impact factor: 1.826

7.  Measurement of global brain atrophy in Alzheimer's disease with unsupervised segmentation of spin-echo MRI studies.

Authors:  A Brunetti; A Postiglione; E Tedeschi; A Ciarmiello; M Quarantelli; E M Covelli; G Milan; M Larobina; A Soricelli; A Sodano; B Alfano
Journal:  J Magn Reson Imaging       Date:  2000-03       Impact factor: 4.813

8.  Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life.

Authors:  D D Blatter; E D Bigler; S D Gale; S C Johnson; C V Anderson; B M Burnett; N Parker; S Kurth; S D Horn
Journal:  AJNR Am J Neuroradiol       Date:  1995-02       Impact factor: 3.825

9.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

10.  Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.

Authors:  Robert Zivadinov; Attilio Grop; Jitendra Sharma; Alessio Bratina; Christopher W Tjoa; Michael Dwyer; Marino Zorzon
Journal:  J Neuroimaging       Date:  2005-01       Impact factor: 2.486

View more
  9 in total

1.  Postmortem validation of MRI cortical volume measurements in MS.

Authors:  Veronica Popescu; Roel Klaver; Adriaan Versteeg; Pieter Voorn; Jos W R Twisk; Frederik Barkhof; Jeroen J G Geurts; Hugo Vrenken
Journal:  Hum Brain Mapp       Date:  2016-03-04       Impact factor: 5.038

2.  Automated segmentation method of white matter and gray matter regions with multiple sclerosis lesions in MR images.

Authors:  Taiki Magome; Hidetaka Arimura; Shingo Kakeda; Daisuke Yamamoto; Yasuo Kawata; Yasuo Yamashita; Yoshiharu Higashida; Fukai Toyofuku; Masafumi Ohki; Yukunori Korogi
Journal:  Radiol Phys Technol       Date:  2010-09-30

3.  Segmentation priors from local image properties: without using bias field correction, location-based templates, or registration.

Authors:  Andrej Vovk; Robert W Cox; Janez Stare; Dusan Suput; Ziad S Saad
Journal:  Neuroimage       Date:  2010-12-10       Impact factor: 6.556

4.  Impact of Markov Random Field optimizer on MRI-based tissue segmentation in the aging brain.

Authors:  Christopher G Schwarz; Alex Tsui; Evan Fletcher; Baljeet Singh; Charles DeCarli; Owen Carmichael
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2011

5.  Clinical Factors Associated with Brain Volume Reduction in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations.

Authors:  Shuang Liu; Yuqi Cheng; Yueyin Zhao; Hongjun Yu; Aiyun Lai; Zhaoping Lv; Xiufeng Xu; Chunrong Luo; Baoci Shan; Lin Xu; Jian Xu
Journal:  Front Psychiatry       Date:  2018-02-01       Impact factor: 4.157

6.  Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS.

Authors:  Jan-Patrick Stellmann; Hanife Cetin; Kim Lea Young; Sibylle Hodecker; Jana Pöttgen; Diana Bittersohl; Andrea Hassenstein; Timm Oberwahrenbrock; Christoph Heesen; Susanne Siemonsen
Journal:  Brain Behav       Date:  2016-12-20       Impact factor: 2.708

7.  SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology.

Authors:  Christian P Kamm; Heinrich P Mattle
Journal:  Trials       Date:  2009-12-14       Impact factor: 2.279

8.  Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial.

Authors:  Christian Philipp Kamm; Marwan El-Koussy; Sebastian Humpert; Oliver Findling; Ferdinand von Bredow; Yuliya Burren; Guido Schwegler; Dagmar Schött; Filippo Donati; Martin Müller; Norbert Goebels; Felix Müller; Johannes Slotboom; Barbara Tettenborn; Ludwig Kappos; Yvonne Naegelin; Heinrich Paul Mattle
Journal:  J Neurol       Date:  2012-05-09       Impact factor: 4.849

9.  Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial.

Authors:  Christian P Kamm; Marwan El-Koussy; Sebastian Humpert; Oliver Findling; Yuliya Burren; Guido Schwegler; Filippo Donati; Martin Müller; Felix Müller; Johannes Slotboom; Ludwig Kappos; Yvonne Naegelin; Heinrich P Mattle
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.